51,150 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Bought by Jackson Creek Investment Advisors LLC

Jackson Creek Investment Advisors LLC bought a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 51,150 shares of the company's stock, valued at approximately $1,788,000. Option Care Health accounts for 0.6% of Jackson Creek Investment Advisors LLC's portfolio, making the stock its 16th biggest position.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Raymond James Financial Inc. purchased a new position in shares of Option Care Health in the 4th quarter valued at about $2,027,000. Madison Investment Advisors LLC purchased a new stake in Option Care Health in the fourth quarter valued at approximately $4,135,000. Cibc World Markets Corp purchased a new stake in Option Care Health in the fourth quarter valued at approximately $373,000. Signaturefd LLC raised its stake in shares of Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after purchasing an additional 1,005 shares during the last quarter. Finally, Xponance Inc. raised its stake in shares of Option Care Health by 3.9% during the fourth quarter. Xponance Inc. now owns 25,056 shares of the company's stock worth $581,000 after purchasing an additional 944 shares during the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Stock Down 1.5%

NASDAQ OPCH traded down $0.46 during mid-day trading on Friday, reaching $29.48. 954,581 shares of the company's stock traded hands, compared to its average volume of 1,828,047. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The company has a fifty day simple moving average of $31.58 and a 200-day simple moving average of $31.61. The company has a current ratio of 1.54, a quick ratio of 1.02 and a debt-to-equity ratio of 0.82. The company has a market cap of $4.83 billion, a price-to-earnings ratio of 23.77, a P/E/G ratio of 1.81 and a beta of 0.73.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.36 by $0.04. The company had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a return on equity of 16.90% and a net margin of 4.12%. The business's revenue was up 16.3% on a year-over-year basis. During the same quarter last year, the firm earned $0.26 EPS. As a group, equities research analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

Wall Street Analyst Weigh In

OPCH has been the topic of a number of recent analyst reports. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. JMP Securities reaffirmed a "market outperform" rating and set a $36.00 price objective on shares of Option Care Health in a report on Wednesday, June 18th. Finally, Barrington Research reaffirmed an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a report on Thursday, July 10th. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $35.50.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.